|
Targeted Drug Development for Abnormal Proliferation
Applications
Target for drug development for diseases involving abnormal proliferation of cells, including psoriasis (hyperproliferation of skin cells) and benign prostatic hypertrophy.
Technical Summary
Reactive oxygen intermediates (ROI) are generated during an oxidative process that occurs in many cell types. The result of generating reactive...
Published: 11/27/2023
Contributor(s): John David Lambeth, Bernard Lassegue, Kathy Griendling, Rebecca Arnold, Guang Cheng
|